In fiscal year 2025, GFC Life Science (388610) reported revenue of 17.7 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 17.7 billion KRW | 386 million KRW | 555 million KRW | [source] |
| 2024 | 16.8 billion KRW | 1.7 billion KRW | -5.9 billion KRW | [source] |
| 2023 | 15.4 billion KRW | 704 million KRW | 2.1 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 33.8 billion KRW | 10.0 billion KRW | 23.8 billion KRW | [source] |
| 2024 | 20.1 billion KRW | 9.2 billion KRW | 10.9 billion KRW | [source] |
| 2023 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.